Article ID Journal Published Year Pages File Type
6113334 Critical Reviews in Oncology/Hematology 2016 7 Pages PDF
Abstract

Short non-coding microRNAs have been identified to orchestrate crucial mechanisms in cancer progression and treatment resistance. MicroRNAs are involved in posttranscriptional modulation of gene expression and therefore represent promising targets for anticancer therapy. As mircoRNA-1 (miR-1) exerted to be predominantly downregulated in the majority of examined tumors, miR-1 is classified to be a tumor suppressor with high potential to diminish tumor development and therapy resistance. Here we review the complex functionality of miR-1 in tumor biology.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , ,